#RIA

Immunological Applications

RIA stands for:

Radioimmunoassay developed by Solomon Berson and Rosalyn Yalow 1960 represented first method achieving picogram sensitivity for protein hormone quantification, earning Nobel Prize Physiology 1977. Principle competitive: fixed limiting amount of specific antibody incubated with constant amount of radiolabeled antigen tracer and variable unlabeled sample. Radiolabel typically iodine-125 introduced onto tyrosine residues via chloramine T oxidation producing reactive iodonium ion electrophilically substituting aromatic ring or via lactoperoxidase enzymatic iodination preserving biological activity, specific activity up to 100 microcurie per microgram allowing gamma counting, half-life 60 days. Unlabeled analyte competes for antibody binding sites reducing bound tracer proportionally. Separation of bound versus free fractions achieved by precipitation with secondary anti-immunoglobulin antibody forming insoluble immune complex, or polyethylene glycol 6000 increasing macromolecular crowding causing precipitation, or charcoal adsorption of free antigen. Bound radioactivity measured in gamma counter, Scatchard plot analysis yields affinity constant and concentration via dose-response curve. Sensitivity reaches low picogram per ml for insulin enabling discovery of hormone heterogeneity and antibodies in diabetic sera.

Ref: Berson & Yalow J Clin Invest 1960 39:1157 Radioimmunoassay iodine-125; Lodish Molecular Biology competitive binding tracer.

View Details

Immunological Applications

RIA stands for:

Radioimmunoassay RIA competitive binding assay pioneered Berson Yalow 1960 Nobel Prize Medicine 1977 enabled first quantification peptide hormones insulin glucagon pg concentrations revolutionizing endocrinology. Principle relies limited antibody binding sites fixed high-affinity polyclonal antibody specific analyte insulin 51 aa thyroxine T4 triiodothyronine growth hormone 191 aa incubated known quantity iodine-125 labeled antigen purified chloramine T oxidizing iodide iodine incorporating tyrosine achieving specific activity 50-100 uCi per ug variable unknown unlabeled sample antigen competing same paratope via mass action competitive inhibition law mass action. Equilibrium 24h 4 degrees balancing association dissociation. Separation free bound fractions essential via second antibody precipitation goat anti-rabbit Ig forming insoluble complexes centrifuged 3000 g dextran-coated charcoal adsorbing free small antigen

Ref: Yalow and Berson 1960 RIA J Clin Invest Nobel Method; NCBI StatPearls Radioimmunoassay Principles https://www.ncbi.nlm.nih.gov/books/NBK557486/; Janeway RIA Technique Immunoassay Chapter 3.

View Details

Flow cytometry, FACS, ELISA

What happens to radioactive signal in RIA if antigen is high?

Radioimmunoassay principle involves fixed limited antibody, fixed trace amount of radiolabeled antigen, and variable unlabeled antigen from sample competing for binding. At equilibrium, higher concentration of unlabeled antigen occupies more antibody sites, displacing labeled antigen into free fraction that is washed away. Radioactivity measured in bound pellet therefore decreases as sample antigen increases. This inverse relationship allows construction of standard curve. No change or direct proportionality would violate competition kinetics, equal distribution would indicate no affinity. Bound counts fall with rising antigen levels.

Ref: NCERT Biology Class XII Principles on Klenow fill-in labeling, Lehninger Chapter 9 DNA cloning techniques, and Molecular Cloning by Sambrook Chapter 10 documenting end-labeling of cohesive termini.

View Details

Flow cytometry, FACS, ELISA

In RIA, diabetic patients show:

Radioimmunoassay is competitive binding assay where fixed amount of radiolabeled antigen competes with unlabeled patient antigen for limited antibody. Bound radioactivity is inversely proportional to patient antigen concentration. In type one diabetes low insulin secretion occurs due to beta cell destruction. With little cold insulin to compete, antibody binds predominantly hot labeled insulin, so precipitated complex retains high radioactivity counts. High insulin sample would displace hot insulin and lower counts. Therefore diabetic insulin deficient samples show low circulating insulin but high bound radioactivity reading, indicating hormone deficiency.

Ref: NCERT Biology Class XII Principles on Klenow fill-in labeling, Lehninger Chapter 9 DNA cloning techniques, and Molecular Cloning by Sambrook Chapter 10 documenting end-labeling of cohesive termini.

View Details

Microscopy

In RIA, what happens when sample antigen concentration increases?

Radioimmunoassay operates competitively with fixed amounts of specific antibody and radiolabeled antigen. Unlabeled antigen from sample and labeled antigen contend for same binding pocket. When clinical sample contains abundant antigen, it occupies most antibody sites, displacing radioactive tracer into wash fraction. After separation of bound and free fractions, retained radioactivity declines proportionally to sample concentration. Thus calibration curve shows inverse relationship between counts per minute and analyte level. This displacement principle enables precise interpolation of unknown hormone or drug levels using standard curve plotting decreasing bound radioactivity.

Ref: NCERT Biology Class XII Principles on Klenow fill-in labeling, Lehninger Chapter 9 DNA cloning techniques, and Molecular Cloning by Sambrook Chapter 10 documenting end-labeling of cohesive termini.

View Details